ONTODIA

Ontodia, Inc., is an open data solutions firm based in New York City. Ontodia provides solutions for unlocking the potential of open data, for governments of all sizes, and sectors that utilize open data. Our open data services include open data publishing, data wrangling, and data visualization.
ONTODIA
Industry:
Analytics Big Data Data Visualization Publishing Semantic Web Software
Founded:
2011-10-25
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.ontodia.com
Total Employee:
1+
Status:
Active
Contact:
8482501538
Email Addresses:
[email protected]
Total Funding:
350 K USD
Technology used in webpage:
IPv6 Google Apps For Business GStatic Google Static Content Cloudflare Hosting Cloudflare DNS
Similar Organizations
Deduce
Deduce provides real-time analytics profiling and scoring to detect and prevent bad actors and account takeover.
LnData
LnData helps brands make quick and smart decision in digital marketing.
Pellucid Analytics
Pellucid is a content platform and service specifically for pitchbook creation.
Piano
Piano helps organizations understand and influence customer behavior through one complete platform.
Quantium
Quantium is an IT company that delivers solutions in data and technology for individuals, society, and organizations.
Current Employees Featured
Founder
Official Site Inspections
http://www.ontodia.com
- Host name: 172.67.218.110
- IP address: 172.67.218.110
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Ontodia"
Home - Oncodia AB
Nov 10, 2023 Oncodia is an innovative Medical Technology company based in Uppsala, Sweden. We are committed to providing in vitro diagnostic products that consistently meet customer needs, enhance patient treatment outcomes and โฆSee details»
Oncodia AB - LinkedIn
Oncodia AB, an innovative young company from the medical technology industry. More precisely, we are developing CE/IVD-certified software for precision cancer medicine and we are โฆSee details»
Oncodia AB - Crunchbase Company Profile & Funding
Organization. Oncodia AB . Connect to CRM . Save . Summary. People. Technology. Signals & News. About. Oncodia AB. Uppsala, Uppsala Lan ... There is no recent news or activity for this โฆSee details»
Oncodia AB has moved to new premises
Apr 1, 2020 Oncodia. Precision Medicine Delivered. Our vision is a world where every cancer patient receives the right therapy.See details»
Oncodia Company Profile 2024: Valuation, Funding & Investors
Oncodia is headquartered in Uppsala, Sweden. What is the size of Oncodia? Oncodia has 10 total employees. What industry is Oncodia in? Oncodiaโs primary industry is Decision/Risk Analysis. โฆSee details»
Oncodia - Products, Competitors, Financials, Employees, โฆ
Oncodia is committed to providing in vitro diagnostic products that consistently meet customer needs, enhance patient treatment outcomes and adhere to regulatory and statutory โฆSee details»
Oncodia AB Overview | SignalHire Company Profile
Organization Website: oncodia.com : Social Links: Oncodia AB industries Medtech: Headquarters Location: Knivstagatan 8, Uppsala, Uppsala ... Oncodia AB headquarters is in Uppsala, โฆSee details»
Oncodia AB - Company profile | ensun
Oncodia has received funding from the European Unionโs Horizon 2020 research and innovation programme under grant agreement No 876876. Oncodia has the pleasure to announce the โฆSee details»
Oncodia Company Profile: Funding, Investors & Partnerships
Oct 15, 2022 Oncodia AB, an innovative young company from the medical technology industry. More precisely, we are developing CE/IVD-certified software for precision cancer medicine โฆSee details»
ONCODIA AB - VentureRadar
Aug 1, 2019 Title: Regulatory Approved Software for Mutation Analysis in Cancer (Acronym: RASMAC) | Total Cost: โฌ71429 / EU contribution: โฌ50000 | Start: 2019-08-01 End: 2020-01-31See details»
Oncodia - Overview, News & Similar companies | ZoomInfo.com
Who is Oncodia. We are committed to providing in vitro diagnostic products that consistently meet customer needs, enhance patient treatment outcomes and adhere to regulatory and statutory โฆSee details»
Oncodia - Uppsala University Invest
Oncodia develops and sells CE / IVD-labeled, automated extraction methods as well as software for analyzing sequencing data with fast performance and high precision to facilitate and guide โฆSee details»
Ontodia Company Profile 2024: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for Ontodia. Use the PitchBook Platform to explore the full profile.See details»
Oncodia AB - Contacts, Employees, Board Members, Advisors
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.See details»
ONCODIA AB - VentureRadar
ONCODIA AB VentureRadar profile. Find out more about ONCODIA AB including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Svenskt cancerdiagnostikbolag tar in 8,5 miljoner kronor
Apr 25, 2022 Oncodia har utvecklat en mjukvara som möjliggör analys av generisk information från tumörer, vilket är till hjälp i valet av anpassad behandling, det rapporterar Life Science โฆSee details»
Oncodia AB - DevelopmentAid
Oncodia AB โ Supplier from Sweden, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Information & Communication Technology sectorsSee details»
Oncodia - Uppsala University Invest
Oncodia utvecklar och säljer CE/IVD-märkta, automatiserade extraktionsmetoder samt mjukvara för analys av sekvenseringsdata med snabb prestanda och hög precision för att underlätta och โฆSee details»
Carl Tobias | Oncodia | HealthTech Alpha
Carl Tobias is Board Member of Oncodia. Discover Digital Health profiles, team, funding and valuation with HealthTech Alpha.See details»
OpenGov acquires Ontodia to add open-sourced data to its civic ...
Apr 13, 2016 After raising $25 million in additional funding in October, civic technology specialist OpenGov โ the startup co-founded by Palantirโs Joe Lonsdale that works with government โฆSee details»